ROBINUL-NEOSTIGMINE 0.5mg / ml 2.5mg / ml injectible solution medication leaflet

A03AB02 glycopyrronium bromide + neostigmine methylsulfate • Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Synthetic anticholinergics, quaternary ammonium compounds

Glycopyrronium bromide + neostigmine methylsulfate is a combination of medications used to reverse the effects of muscle relaxants administered during surgery. It helps restore normal muscle function after general anesthesia.

Glycopyrronium bromide is an anticholinergic agent that reduces side effects such as excessive secretions or bradycardia (slowed heart rate) caused by neostigmine. Neostigmine methylsulfate is a cholinesterase inhibitor that increases acetylcholine levels, aiding in the restoration of muscle contraction.

This combination is effective and well-tolerated but may cause side effects such as dry mouth, nausea, dizziness, or changes in heart rate. It is important for the medication to be administered under strict medical supervision, usually in a hospital setting.

General data about ROBINUL-NEOSTIGMINE 0.5mg / ml 2.5mg / ml

Substance: glycopyrronium bromide + neostigmine methylsulfate

Date of last drug list: 01-06-2025

Commercial code: W69292001

Concentration: 0.5mg / ml 2.5mg / ml

Pharmaceutical form: injectible solution

Quantity: 10

Product type: generic

Price: 196.80 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: EUMEDICA PHARMACEUTICALS GMBH - GERMANIA

Holder: CN UNIFARM S.A. - ROMANIA

Number: 765/2022/01

Other substances similar to glycopyrronium bromide + neostigmine methylsulfate